196 related articles for article (PubMed ID: 34757548)
1. ASO Author Reflections: Value of Sentinel Node Biopsy for Chest Wall Recurrence After Mastectomy.
Vicini E; Fontana SKR; Leonardi MC; Veronesi P; Galimberti V
Ann Surg Oncol; 2022 Mar; 29(3):1761-1762. PubMed ID: 34757548
[No Abstract] [Full Text] [Related]
2. ASO Author Reflections: A Perspective on Nonsentinel Axillary Lymph Node Status in Sentinel Lymph Node-Positive Early Breast Cancer After Primary Systemic Therapy and ALND-Predict.
Cebrecos I; Mension E; Vidal M; Schettini F
Ann Surg Oncol; 2023 Sep; 30(9):5705-5706. PubMed ID: 36820935
[No Abstract] [Full Text] [Related]
3. ASO Author Reflections: Standardizing Pathology Examination of Sentinel Lymph Nodes in Invasive Lobular Carcinoma: Less Is More.
Hieken TJ; Solanki MH
Ann Surg Oncol; 2022 Oct; 29(10):6466-6467. PubMed ID: 35930110
[No Abstract] [Full Text] [Related]
4. ASO Author Reflections: Trends of Axillary Treatment in Sentinel Node-Positive Breast Cancer Patients Undergoing Mastectomy.
Verreck E; van Steenhoven J; van Dalen T
Ann Surg Oncol; 2023 Sep; 30(9):5633-5634. PubMed ID: 37378845
[No Abstract] [Full Text] [Related]
5. ASO Author Reflections: Refining Risk Assessment in Node-Positive Breast Cancer Patients Eligible for Sentinel Lymph Node Biopsy Alone.
Mamtani A; Morrow M
Ann Surg Oncol; 2020 Oct; 27(10):3593-3594. PubMed ID: 32440719
[No Abstract] [Full Text] [Related]
6. ASO Author Reflections: Positive Sentinel Lymph Node in Breast Cancer Surgery.
Millen EC; Cavalcante FP
Ann Surg Oncol; 2022 Feb; 29(2):1096-1097. PubMed ID: 34561776
[No Abstract] [Full Text] [Related]
7. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome.
Johnson J; Esserman L; Ewing C; Alvarado M; Park C; Fowble B
Ann Surg Oncol; 2016 Mar; 23(3):715-21. PubMed ID: 26714943
[TBL] [Abstract][Full Text] [Related]
8. ASO Author Reflections: Low Rates of Axillary Recurrence in Clinically Node-Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Alone Following Pathologic Response to Neoadjuvant Chemotherapy.
Wong SM; Boileau JF
Ann Surg Oncol; 2021 May; 28(5):2630-2631. PubMed ID: 33123855
[No Abstract] [Full Text] [Related]
9. ASO Author Reflections: Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy for Node-Positive Breast Cancer: Is It Oncologically Safe?
Piltin MA; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):707-708. PubMed ID: 32737696
[No Abstract] [Full Text] [Related]
10. ASO Author Reflections: Sentinel Lymph Node Removal After Neoadjuvant Chemotherapy in Clinically Node-Negative Patients Can Stop After Removal of Three Lymph Nodes.
Murphy BL; Boughey JC
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):848-849. PubMed ID: 32696307
[No Abstract] [Full Text] [Related]
11. ASO Author Reflections: MicroRNA-Based Nomogram for Prediction of Sentinel Lymph Node Metastasis in ER+/HER2- Breast Cancer in Hoping for a Possible Omission of Sentinel Lymph Node Biopsy.
Okuno J; Miyake T; Shimazu K; Noguchi S
Ann Surg Oncol; 2020 Dec; 27(Suppl 3):810-811. PubMed ID: 32632881
[No Abstract] [Full Text] [Related]
12. ASO Author Reflections: Objective Outcome Measure of Upper Limb Function Following Axillary Lymph Node Dissection and Sentinel Lymph Node Biopsy.
Che Bakri NA; Kwasnicki RM; Giannas E; Tenang L; Khan N; Moenig C; Imam Z; Dhillon K; Ashrafian H; Darzi A; Leff DR
Ann Surg Oncol; 2023 Nov; 30(12):7133-7134. PubMed ID: 37482598
[No Abstract] [Full Text] [Related]
13. Sentinel Lymph Node Biopsy in Breast Cancer Surgery.
Dixon JM
Ann Surg Oncol; 2016 Oct; 23(11):3426-3428. PubMed ID: 27448117
[No Abstract] [Full Text] [Related]
14. Author response to: Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study.
Gentile D; Tinterri C
Br J Surg; 2023 Nov; 110(12):1905. PubMed ID: 37815150
[No Abstract] [Full Text] [Related]
15. ASO Author Reflections: Fluorescence-Guided Sentinel Node Biopsy for Breast Cancer.
Kedrzycki MS; Elson DS; Leff DR
Ann Surg Oncol; 2021 Jul; 28(7):3749-3750. PubMed ID: 33185734
[No Abstract] [Full Text] [Related]
16. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
17. A regression model to predict axillary high tumor burden in sentinel node-positive breast cancer patients.
Barco I; García-Font M; García-Fernández A; Giménez N; Fraile M; González S; Vallejo E; Lain JM; Vidal M; González C; Larrañaga I; Canales L; Pessarrodona A; Chabrera C
Breast J; 2020 Feb; 26(2):322-324. PubMed ID: 31493303
[No Abstract] [Full Text] [Related]
18. Redefining axillary lymph node dissection in mastectomy: insights from the SINODAR-ONE study.
Mokbel K; Almoodi M
Br J Surg; 2023 Nov; 110(12):1903. PubMed ID: 37815157
[No Abstract] [Full Text] [Related]
19. Axillary Surgery for Early-Stage, Node-Positive Mastectomy Patients and the Use of Postmastectomy Chest Wall Radiation Therapy.
Gaines S; Suss N; Barrera E; Pesce C; Kuchta K; Winchester DJ; Yao K
Ann Surg Oncol; 2018 Aug; 25(8):2220-2228. PubMed ID: 29626303
[TBL] [Abstract][Full Text] [Related]
20. Factors Predictive of Sentinel Lymph Node Involvement in Primary Breast Cancer.
Malter W; Hellmich M; Badian M; Kirn V; Mallmann P; Krämer S
Anticancer Res; 2018 Jun; 38(6):3657-3662. PubMed ID: 29848724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
